Overview

Intravesical BCG Administration to Patients With Invasive Bladder Cancer

Status:
Terminated
Trial end date:
2019-04-25
Target enrollment:
Participant gender:
Summary
Patients with invasive bladder cancer will be given 3-6 treatments (based on treatment response) BCG intravesically followed by a cystectomy.
Phase:
N/A
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio